SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 39 filers reported holding SCPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,369 | -53.7% | 6,372 | -33.7% | 0.00% | – |
| Q2 2023 | $97,885 | +39.8% | 9,606 | -9.3% | 0.00% | – |
| Q1 2021 | $70,000 | +25.0% | 10,596 | 0.0% | 0.00% | – |
| Q4 2020 | $56,000 | -6.7% | 10,596 | +30.8% | 0.00% | – |
| Q3 2020 | $60,000 | 0.0% | 8,104 | 0.0% | 0.00% | – |
| Q2 2020 | $60,000 | +93.5% | 8,104 | -22.2% | 0.00% | – |
| Q1 2019 | $31,000 | -20.5% | 10,410 | 0.0% | 0.00% | – |
| Q4 2018 | $39,000 | -36.1% | 10,410 | 0.0% | 0.00% | – |
| Q3 2018 | $61,000 | +3.4% | 10,410 | 0.0% | 0.00% | – |
| Q2 2018 | $59,000 | -57.6% | 10,410 | -7.3% | 0.00% | – |
| Q1 2018 | $139,000 | – | 11,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,857,143 | $35,429,000 | 2.71% |
| Orbimed Advisors | 3,409,865 | $42,282,000 | 0.52% |
| AWM Investment Company, Inc. | 213,317 | $2,645,000 | 0.51% |
| DAFNA Capital Management LLC | 55,844 | $692,000 | 0.34% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 40,373 | $501,000 | 0.07% |
| Alyeska Investment Group, L.P. | 223,438 | $2,771,000 | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 24,330 | $302,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 69,500 | $862,000 | 0.01% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 36,206 | $449,000 | 0.00% |
| PEDDOCK CAPITAL ADVISORS, LLC | 100 | $1,000 | 0.00% |